Subdividing NSCLC: reflections on the past, present, and future of lung cancer therapy.
Argiris
Athanassios
A
Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh School of Medicine and University of Pittsburgh Cancer Institute, USA.
Gadgeel
Shirish M
SM
Dacic
Sanja
S
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000145:classification* / Q000628:therapy*; D005544:Forecasting; D006801:Humans; D008175:Lung Neoplasms / Q000145:classification* / Q000628:therapy*; D008495:Medical Oncology / Q000639:trends
D000970:Antineoplastic Agents